Pacific Shuanglin Bio-pharmacy Co., Ltd. (000403) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Pacific Shuanglin Bio-pharmacy Co., Ltd.

Why is Pacific Shuanglin Bio-pharmacy Co., Ltd. ?

With a fall in Net Sales of -16.23%, the company declared Very Negative results in Sep 25

The company has declared negative results for the last 2 consecutive quarters
The company has declared negative results in Dec 24 after 4 consecutive negative quarters
OPERATING CASH FLOW(Y) Lowest at CNY 78.7 MM
ROCE(HY) Lowest at 7.06%
NET SALES(Q) At CNY 631.66 MM has Fallen at -16.23%

Consistent Underperformance against the benchmark over the last 3 years

Along with generating -23.09% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in each of the last 3 annual periods

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Pacific Shuanglin Bio-pharmacy Co., Ltd. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Pacific Shuanglin Bio-pharmacy Co., Ltd.

-22.18%

-1.10

35.78%

China Shanghai Composite

15.17%

1.02

14.86%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

20.57%

EBIT Growth (5y)

28.06%

EBIT to Interest (avg)

51.60

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.10

Sales to Capital Employed (avg)

0.30

Tax Ratio

12.64%

Dividend Payout Ratio

37.71%

Pledged Shares

Institutional Holding

ROCE (avg)

8.78%

ROE (avg)

7.31%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.97

EV to EBIT

21.52

EV to EBITDA

17.99

EV to Capital Employed

2.01

EV to Sales

6.12

PEG Ratio

Dividend Yield

1.98%

ROCE (Latest)

9.35%

ROE (Latest)

8.12%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

Bearish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Mildly Bullish

Bearish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

0What is working for the Company

NO KEY POSITIVE TRIGGERS

-41What is not working for the Company

OPERATING CASH FLOW(Y)

Lowest at CNY 78.7 MM

ROCE(HY)

Lowest at 7.06%

NET SALES(Q)

At CNY 631.66 MM has Fallen at -16.23%

INTEREST COVERAGE RATIO(Q)

Lowest at 2,274.95

PRE-TAX PROFIT(Q)

At CNY 137.58 MM has Fallen at -43.98%

NET PROFIT(Q)

At CNY 121.02 MM has Fallen at -43.2%

RAW MATERIAL COST(Y)

Grown by 11.31% (YoY

DEBT-EQUITY RATIO (HY)

Highest at -2.48 %

INVENTORY TURNOVER RATIO(HY)

Lowest at 0.92 times

DEBTORS TURNOVER RATIO(HY)

Lowest at 3.46 times

INTEREST(Q)

Highest at CNY 5.76 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 20.76 %

Here's what is not working for Pacific Shuanglin Bio-pharmacy Co., Ltd.

Net Sales

At CNY 631.66 MM has Fallen at -16.23%

Year on Year (YoY)

MOJO Watch

Near term sales trend is very negative

Net Sales (CNY MM)

Interest

At CNY 5.76 MM has Grown at 64.23%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Interest Coverage Ratio

Lowest at 2,274.95

in the last five periods

MOJO Watch

The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Pre-Tax Profit

At CNY 137.58 MM has Fallen at -43.98%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CNY MM)

Net Profit

At CNY 121.02 MM has Fallen at -43.2%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (CNY MM)

Operating Cash Flow

Lowest at CNY 78.7 MM

in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Interest

Highest at CNY 5.76 MM

in the last five periods and Increased by 64.23% (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Operating Profit Margin

Lowest at 20.76 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Debt-Equity Ratio

Highest at -2.48 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Inventory Turnover Ratio

Lowest at 0.92 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Debtors Turnover Ratio

Lowest at 3.46 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Raw Material Cost

Grown by 11.31% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales